Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
4.720
+0.120 (2.61%)
At close: Dec 20, 2024, 4:00 PM
4.700
-0.020 (-0.42%)
After-hours: Dec 20, 2024, 7:31 PM EST
Precision BioSciences Stock Forecast
DTIL's stock price has decreased by -56.42% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for DTIL stock have an average target of 39.5, with a low estimate of 19 and a high estimate of 60. The average target predicts an increase of 736.86% from the current stock price of 4.72.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 22, 2024.
Analyst Ratings
The average analyst rating for DTIL stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,171.19% | Aug 22, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,171.19% | May 30, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,171.19% | May 16, 2024 |
Guggenheim | Guggenheim | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +302.54% | Apr 30, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,171.19% | Apr 17, 2024 |
Financial Forecast
Revenue This Year
73.25M
from 48.73M
Increased by 50.33%
Revenue Next Year
20.43M
from 73.25M
Decreased by -72.12%
EPS This Year
1.87
from -15.96
EPS Next Year
-6.91
from 1.87
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 81.4M | 47.9M | 69.8M | |||
Avg | 73.3M | 20.4M | 32.4M | |||
Low | 66.7M | 4.9M | 12.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 67.0% | -34.6% | 241.8% | |||
Avg | 50.3% | -72.1% | 58.5% | |||
Low | 36.9% | -93.3% | -40.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.74 | -1.10 | 0.06 | ||
Avg | 1.87 | -6.91 | -4.66 | ||
Low | 1.04 | -10.76 | -6.77 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.